BioTelemetry Company Profile (NASDAQ:BEAT)

About BioTelemetry

BioTelemetry logoBioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment's principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. The Company's research services focuses on providing cardiac safety monitoring services for drug and medical treatment trials in a research environment. In August 2012, the Company completed the acquisition of Cardiocore Lab, Inc. (Cardiocore).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BEAT
  • CUSIP:
Key Metrics:
  • Previous Close: $19.12
  • 50 Day Moving Average: $19.38
  • 200 Day Moving Average: $15.19
  • Trailing P/E Ratio: 41.04
  • Foreward P/E Ratio: 23.24
  • P/E Growth: 0.00
  • Market Cap: $540.60M
  • Outstanding Shares: 28,025,000
  • Beta: 1.11
Additional Links:
Companies Related to BioTelemetry:

Analyst Ratings

Consensus Ratings for BioTelemetry (NASDAQ:BEAT) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.00 (29.60% upside)

Analysts' Ratings History for BioTelemetry (NASDAQ:BEAT)
DateFirmActionRatingPrice TargetDetails
8/3/2016Benchmark Co.Boost Price TargetBuy$20.00 -> $25.00View Rating Details
7/28/2015Dougherty & CoBoost Price TargetBuy$18.00 -> $20.00View Rating Details
11/24/2014Avondale PartnersUpgradeMarket Perform -> OutperformView Rating Details
(Data available from 8/28/2014 forward)


Earnings History for BioTelemetry (NASDAQ:BEAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q2$0.17$0.20$50.27 million$52.68 millionViewListenView Earnings Details
4/26/2016Q1$0.10$0.20$46.54 million$48.60 millionViewListenView Earnings Details
2/17/2016Q415$0.11$0.15$45.89 million$46.70 millionViewListenView Earnings Details
11/9/2015Q3$0.11$0.13$46.05 million$43.49 millionViewN/AView Earnings Details
8/6/2015Q2$0.09$0.12$45.75 million$44.81 millionViewListenView Earnings Details
5/6/2015Q115$0.02$0.06$43.80 million$43.40 millionViewListenView Earnings Details
2/19/2015Q414$0.06$0.05$43.40 million$43.70 millionViewListenView Earnings Details
10/30/2014Q214$0.02$0.06$42.00 million$43.00 millionViewListenView Earnings Details
7/31/2014Q114$0.01$0.02$40.95 million$42.70 millionViewListenView Earnings Details
5/6/2014Q413($0.02)($0.04)$38.40 million$37.16 millionViewListenView Earnings Details
2/26/2014Q313($0.04)$0.05$32.26 million$33.10 millionViewListenView Earnings Details
11/5/2013($0.05)($0.12)$32.79 million$31.90 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.02$27.50 million$32.10 millionViewListenView Earnings Details
2/13/2013Q4 2012($0.09)$26.80 million$30.00 millionViewListenView Earnings Details
11/5/2012Q312($0.09)($0.08)$26.49 million$27.00 millionViewN/AView Earnings Details
8/8/2012($0.04)($0.01)ViewN/AView Earnings Details
5/8/2012($0.12)($0.10)ViewN/AView Earnings Details
2/22/2012($0.13)($0.04)ViewN/AView Earnings Details
11/8/2011($0.09)($0.21)ViewN/AView Earnings Details
8/8/2011($0.06)($0.05)ViewN/AView Earnings Details
5/3/2011($0.15)($0.02)ViewN/AView Earnings Details
2/17/2011($0.16)($0.13)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for BioTelemetry (NASDAQ:BEAT)
Current Year EPS Consensus Estimate: $0.76 EPS
Next Year EPS Consensus Estimate: $0.83 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.08$0.09$0.09
Q2 20161$0.16$0.16$0.16
Q3 20161$0.18$0.18$0.18
Q4 20161$0.20$0.20$0.20
Q1 20171$0.21$0.21$0.21
Q2 20171$0.20$0.20$0.20
Q3 20171$0.20$0.20$0.20
Q4 20171$0.22$0.22$0.22
(Data provided by Zacks Investment Research)


Dividend History for BioTelemetry (NASDAQ:BEAT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for BioTelemetry (NASDAQ:BEAT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/25/2016Fred BroadwaySVPSell5,877$19.16$112,603.32View SEC Filing  
8/25/2016Heather C GetzCFOSell8,477$19.16$162,419.32View SEC Filing  
8/25/2016Joseph H CapperInsiderSell38,785$19.16$743,120.60View SEC Filing  
8/25/2016Peter FerolaGeneral CounselSell6,289$19.16$120,497.24View SEC Filing  
8/24/2016George HrenkoSVPSell7,473$20.11$150,282.03View SEC Filing  
8/24/2016Heather C GetzCFOSell8,778$20.11$176,525.58View SEC Filing  
8/24/2016Joseph H CapperCEOSell40,160$20.11$807,617.60View SEC Filing  
8/24/2016Peter FerolaGeneral CounselSell6,512$20.11$130,956.32View SEC Filing  
8/23/2016George HrenkoSVPSell3,165$20.67$65,420.55View SEC Filing  
8/23/2016Heather C GetzCFOSell3,717$20.67$76,830.39View SEC Filing  
8/23/2016Joseph H CapperCEOSell17,008$20.67$351,555.36View SEC Filing  
8/23/2016Peter FerolaGeneral CounselSell2,758$20.67$57,007.86View SEC Filing  
8/22/2016George HrenkoSVPSell4,149$20.85$86,506.65View SEC Filing  
8/22/2016Heather C GetzCFOSell4,874$20.85$101,622.90View SEC Filing  
8/22/2016Joseph H CapperCEOSell22,298$20.85$464,913.30View SEC Filing  
8/22/2016Peter FerolaGeneral CounselSell3,616$20.85$75,393.60View SEC Filing  
8/19/2016Daniel WisniewskiSVPSell9,025$20.96$189,164.00View SEC Filing  
8/19/2016Heather C GetzCFOSell9,026$20.96$189,184.96View SEC Filing  
8/19/2016Joseph H CapperInsiderSell9,049$20.96$189,667.04View SEC Filing  
8/19/2016Peter FerolaGeneral CounselSell9,035$20.96$189,373.60View SEC Filing  
5/9/2014Ronald AhrensDirectorBuy6,000$7.37$44,220.00View SEC Filing  
11/12/2013Ronald AhrensDirectorBuy5,000$11.73$58,650.00View SEC Filing  
11/12/2012Ronald A AhrensDirectorBuy15,000$2.22$33,300.00View SEC Filing  
9/5/2012Joseph H CapperCEOBuy23,540$2.25$52,965.00View SEC Filing  
8/31/2012Joseph H CapperCEOBuy2,600$2.28$5,928.00View SEC Filing  
8/29/2012Joseph H CapperCEOBuy10,800$2.30$24,840.00View SEC Filing  
8/28/2012Joseph H CapperCEOBuy1,300$2.19$2,847.00View SEC Filing  
8/27/2012Joseph H CapperCEOBuy1,600$2.12$3,392.00View SEC Filing  
8/23/2012Joseph H CapperCEOBuy9,600$2.08$19,968.00View SEC Filing  
8/20/2012Joseph H CapperCEOBuy14,160$1.97$27,895.20View SEC Filing  
8/17/2012Joseph H CapperCEOBuy9,800$2.10$20,580.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for BioTelemetry (NASDAQ:BEAT)
DateHeadline logoBioTelemetry, Vonage and TPI Composites Have Dipped (NASDAQ:BEAT) - August 25 at 3:50 PM logoShark Bites: BioTelemetry, Vonage and TPI Composites Have Dipped (NASDAQ:BEAT) - August 25 at 3:50 PM logoBioTelemetry (BEAT) to License Technology to Bloomlife (NASDAQ:BEAT) - August 23 at 9:01 PM logoBIOTELEMETRY, INC. Files SEC form 8-K, Other Events (NASDAQ:BEAT) - August 23 at 9:01 PM logoBioTelemetry, Inc. Agrees to License Proprietary Technology to Bloom Technologies, Inc. for Use in Prenatal Market - GlobeNewswire (press release) (NASDAQ:BEAT) - August 23 at 3:49 PM logo8:16 am BioTelemetry enters a strategic partnership with Bloom Technologies (NASDAQ:BEAT) - August 23 at 3:49 PM logoBioTelemetry, Inc. Agrees to License Proprietary Technology to Bloom Technologies, Inc. for Use in Prenatal Market (NASDAQ:BEAT) - August 23 at 3:49 PM
News IconHC Stocks Alerts: BioTelemetry, Inc. (NASDAQ:BEAT) Tokai ... - share market updates (press release) (NASDAQ:BEAT) - August 22 at 3:50 PM logoWill BioTelemetry, Inc. (NASDAQ:BEAT) Hit $25 Price Target? - Investor Newswire (NASDAQ:BEAT) - August 20 at 3:48 PM logoWhy BioTelemetry (BEAT) Could Be Positioned for a Surge? (NASDAQ:BEAT) - August 18 at 12:12 PM logoEdited Transcript of BEAT earnings conference call or presentation 2-Aug-16 9:00pm GMT (NASDAQ:BEAT) - August 16 at 12:31 PM logoBIOTELEMETRY, INC. Financials (NASDAQ:BEAT) - August 11 at 3:53 PM logoBioTelemetry, Inc. :BEAT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:BEAT) - August 10 at 4:10 PM logoIs BioTelemetry (BEAT) Stock a Solid Choice Right Now? (NASDAQ:BEAT) - August 9 at 4:57 PM
News IconAnalysts Remain Strong on BioTelemetry, Inc. (NASDAQ:BEAT ... - Duncan News (NASDAQ:BEAT) - August 6 at 4:11 PM logoAnalysts Update on Stocks: Endo International plc (NASDAQ:ENDP) , BioTelemetry, Inc. (NASDAQ:BEAT) - Street Updates (NASDAQ:BEAT) - August 4 at 3:54 PM logoBioTelemetry Inc. (BEAT) Jumps 6.31% on August 03 - (NASDAQ:BEAT) - August 4 at 12:23 PM logoBIOTELEMETRY, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:BEAT) - August 3 at 9:28 PM logoNotable movements of Stocks: BioTelemetry, Inc. (NASDAQ:BEAT) , NxStage Medical, Inc. (NASDAQ:NXTM) - Street Updates (NASDAQ:BEAT) - August 3 at 3:50 PM logoBioTelemetry Inc. : BioTelemetry, Inc. Reports Second Quarter 2016 Financial Results (NASDAQ:BEAT) - August 2 at 9:27 PM logoBioTelemetry posts 2Q profit (NASDAQ:BEAT) - August 2 at 9:27 PM logoEarnings Reaction History: BioTelemetry, Inc., 66.7% Follow-Through - Nasdaq (NASDAQ:BEAT) - August 2 at 3:47 PM logoQ2 2016 BioTelemetry Inc Earnings Release - After Market Close (NASDAQ:BEAT) - August 2 at 8:35 AM logoRecent Analysts Ratings of Stocks: BioTelemetry, Inc. (NASDAQ:BEAT) , Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Street Updates (NASDAQ:BEAT) - August 1 at 8:44 AM
News IconHC Stocks Alerts: BioTelemetry, Inc. (NASDAQ:BEAT) Tokai Pharmaceuticals Inc (NASDAQ:TKAI) - share market updates (press release) (NASDAQ:BEAT) - August 1 at 8:44 AM logoBioTelemetry, Inc. (NASDAQ:BEAT) Updated Price Targets - FTSE News (NASDAQ:BEAT) - July 29 at 3:50 PM logoBioTelemetry Inc. (BEAT) Hits New 52-week High During July 26 Session - (NASDAQ:BEAT) - July 29 at 7:58 AM logoBioTelemetry : Announces FDA Approval of Its Next Generation Device, the MCOT Patch (NASDAQ:BEAT) - July 27 at 9:34 PM logoAnalysts Tips to Monitor: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) , BioTelemetry, Inc. (NASDAQ:BEAT) - Street Updates (NASDAQ:BEAT) - July 27 at 3:49 PM logoBioTelemetry's (BEAT) MCOT Patch Approved by U.S. FDA (NASDAQ:BEAT) - July 27 at 12:19 PM
News IconBioTelemetry Inc (BEAT) Gets FDA Approval, Shares Move Up With Trading Volume - BNB Daily (blog) (NASDAQ:BEAT) - July 26 at 9:48 PM logoBioTelemetry Inc. (BEAT) Jumps 7.79% on July 26 - (NASDAQ:BEAT) - July 26 at 9:48 PM logoBioTelemetry, Inc. to Release Second Quarter 2016 Earnings Results on August 2, 2016 (NASDAQ:BEAT) - July 26 at 4:38 PM logoBioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the MCOT™ Patch - GlobeNewswire (press release) (NASDAQ:BEAT) - July 26 at 3:41 PM logoBioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the MCOT™ Patch (NASDAQ:BEAT) - July 26 at 11:27 AM logoBioTelemetry Gets FDA Clearance For Its MCOT Patch (NASDAQ:BEAT) - July 26 at 10:03 AM logoIs $19 Price Target Attainable For BioTelemetry, Inc. (NASDAQ:BEAT)? - Investor Newswire (NASDAQ:BEAT) - July 24 at 8:30 AM logoBioTelemetry Inc. (BEAT) Hits New 52-week High During July 21 Session - (NASDAQ:BEAT) - July 23 at 8:00 AM logoBioTelemetry, Inc. (BEAT) Sees New 52-Week High - Finance Daily (NASDAQ:BEAT) - July 22 at 11:58 AM logoBioTelemetry Inc (NASDAQ:BEAT) Stock Technicals Hit Strength - CML News (NASDAQ:BEAT) - July 22 at 11:58 AM logoBioTelemetry (BEAT) Announces Consent Judgment on InfoBionic (NASDAQ:BEAT) - July 21 at 3:49 PM
News IconIs Buying BioTelemetry, Inc. Here a Winning Strategy? The Stock Just Gapped Up - Consumer Eagle (NASDAQ:BEAT) - July 21 at 12:17 PM
News IconCould BioTelemetry, Inc. Change Direction After Today's Huge Increase? - Consumer Eagle (NASDAQ:BEAT) - July 20 at 4:17 PM
News IconShares Jumping Higher in Session: BioTelemetry, Inc. (NASDAQ:BEAT) - TGP (NASDAQ:BEAT) - July 20 at 4:17 PM logoBioTelemetry, Inc. Announces Its Latest Success in Patent Enforcement - GlobeNewswire (press release) (NASDAQ:BEAT) - July 20 at 4:17 PM logoBioTelemetry, Inc. Announces Its Latest Success in Patent Enforcement (NASDAQ:BEAT) - July 20 at 11:51 AM
News IconShare Performance Summary for: BioTelemetry, Inc. (NASDAQ:BEAT) - Press Telegraph (NASDAQ:BEAT) - July 18 at 3:51 PM logoNext Weeks Broker Price Targets For BioTelemetry, Inc. (NASDAQ:BEAT) - Fiscal Standard (NASDAQ:BEAT) - July 17 at 8:30 AM logoStrong Sell Calls For BioTelemetry, Inc. (NASDAQ:BEAT) At 0 - Investor Newswire (NASDAQ:BEAT) - July 16 at 3:46 PM logoBioTelemetry Inc. (BEAT) Hits New 52-week High During July 13 Session - (NASDAQ:BEAT) - July 15 at 8:04 PM


BioTelemetry (NASDAQ:BEAT) Chart for Sunday, August, 28, 2016

Last Updated on 8/28/2016 by Staff